What Does LDN-27219 Mean?
Use of drug with the treatment method of asthma as monotherapy without a concomitant ICS is contraindicated; use only as additional therapy for clients with bronchial asthma who are currently getting but are inadequately controlled on an ICS; tend not to use drug for patients whose bronchial asthma is adequately managed on low-or medium-dose ICSAn